Condition: ACL - Anterior Cruciate Ligament Rupture · Sponsor: McMaster University
To date, the use of the quadriceps tendon as an autograft option in primary paediatric Anterior Cruciate Ligament (ACL) reconstruction has not been well studied. The 2018 International Olympic Committee (IOC) Consensus Statement now outlines the quadriceps tendon as a possible autograft option. However, no Randomised Control Trial (RCT) has examined the efficacy of the quadriceps tendon autograft in primary paediatric ACL reconstruction compared to the historical "gold-standard" soft-tissue hamstring autograft in this population. In light of its evidence for favourable outcomes in the adult population, and the (albeit limited) evidence showing safety and promise in the paediatric population, clinical equipoise exists for assessing its impact on outcomes in paediatric patients at the index surgery. This is a parallel, international, multi-centre, blinded randomized controlled trial of 352 skeletally-immature (at the time of injury) patients (ages 10-18 years, inclusive) undergoing primary ACL reconstruction to compare the effect of autograft tendon choice (i.e. hamstring versus soft-tissue quadriceps) on the rates of ACL graft failure, return-to-sport, knee function, pain, health-related quality of life and health utility, psychological factors, range of motion and stability, and any other adverse events at 24 months.
This description comes directly from the study's public registry record.
Darren de SA, MD, FRCSC · 9059232126 · darren.desa@medportal.ca
Nicole Simunovic, MSc · (289) 237-3224 · simunon@mcmaster.ca
Always discuss trial participation with your own doctor first.
| McMaster University | Hamilton, Ontario, Canada | Recruiting |
| Children's Hospital of Eastern Ontario | Ottawa, Ontario, Canada | Recruiting |
| Women's College Hospital/Research Institute | Toronto, Ontario, Canada | Recruiting |
| CHU Sainte-Justine | Montreal, Quebec, Canada | Recruiting |
| Shriners Hospitals for Children - Canada | Montreal, Quebec, Canada | Recruiting |
| Kobe University | Kobe, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03896464